Casein Reactivates Dopaminergic Nerve Injury and Intestinal Inflammation with Disturbing Intestinal Microflora and Fecal Metabolites in a Convalescent Parkinson's Disease Mouse Model.

Abstract

Parkinson's disease (PD) is the fastest-growing neurodegenerative disease, with pathogenic causes elusive and short of effective treatment options. Investigations have found that dairy products positively correlate with the onset of PD, but the mechanisms remain unexplored. As casein is an antigenic component in dairy products, this study assessed if casein could exacerbate PD-related symptoms by stimulating intestinal inflammation and unbalanced intestinal flora and be a risk factor for PD. Using a convalescent PD mouse model induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), the results showed casein reduced motor coordination, caused gastrointestinal dysfunction, reduced dopamine content, and induced intestinal inflammation. Meanwhile, casein disturbed gut microbiota homeostasis by increasing the Firmicutes/Bacteroidetes ratio, decreasing α-diversity, and caused abnormal alterations in fecal metabolites. However, these adverse effects of casein attenuated much when it had hydrolyzed by acid or when antibiotics inhibited the intestinal microbiota of the mice. Therefore, our results suggested that casein could reactivate dopaminergic nerve injury and intestinal inflammation and exacerbate intestinal flora disorder and its metabolites in convalescent PD mice. These damaging effects might be related to disordered protein digestion and gut microbiota in these mice. These findings will provide new insights into the impact of milk/dairy products on PD progression and supply information on dietary options for PD patients.

• Authors: Zhengjia Pu, Shuya Liu, Zeming Guo, Xuemei Zhang, Jie Yan, Yong Tang, Hong Xiao, Jieying Gao, Yingli Li, Qunhua Bai
• Journal: Neuroscience (Neuroscience) Vol. 524 Pg. 120-136 (08 01 2023) ISSN: 1873-7544 [Electronic] United States
• PMID: 37321369 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2023 IBRO. Published by Elsevier Ltd. All rights reserved.

Chemical References

• Dopamine
• Caseins
• 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine

Topics

• Humans
• Animals
• Mice
• Parkinson Disease
• Gastrointestinal Microbiome
• Dopamine (pharmacology)
• Caseins (pharmacology)
• Neurodegenerative Diseases
• Inflammation (pathology)
• Mice, Inbred C57BL
• 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (pharmacology)
• Disease Models, Animal